ENDPOINTS

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

Plus, news about Caliway Biopharmaceuticals, Orca Bio, Alterity Therapeutics and Ascentage Pharma: Roivant discontinues rare lung disease drug: The termination, disclosed in Roivant’s fourth-quarter results, follows a Phase 2

Feb 10, 2025 - 16:24
 0
Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal
Plus, news about Caliway Biopharmaceuticals, Orca Bio, Alterity Therapeutics and Ascentage Pharma: Roivant discontinues rare lung disease drug: The termination, disclosed in Roivant’s fourth-quarter results, follows a Phase 2
Read More

Tags:

Previous Article

Newly Minted Ph.D. Studies Phytoplankton with NASA’s FjordPhyto Project

Next Article

Euclid 'dark universe' telescope discovers stunning Einstein ring in warped spac...

Related Posts

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Senators ask FDA to dig into 'misleading' Super Bowl ad...

Feb 9, 2025  0

Roche heads to FDA with Gazyva results in a form of lupus

Roche heads to FDA with Gazyva results in a form of lupus

Feb 9, 2025  0

Vertex operations chief Stuart Arbuckle to retire

Vertex operations chief Stuart Arbuckle to retire

Feb 11, 2025  0